severe lung infection
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male or female patients at the age of 10-70 years; 2. Kidney transplant recipients of receiving relative or cadaver donor's kidney; 3. Patients who can comply to the study protocol; 4. Patients who provide written informed consent to participate in the study after the purpose and nature of the investigation has been clearly explained to them.
Exclusion criteria
Exclusion criteria: 1. Patients who has the severe heart, lung and hematopoietic system diseases; 2. Patients with cancer; 3. Pregnant or nursing (lactating) women; 4. Persons who has the diseases of psychiosis, acrasia and unable to express himself explicitly; 5. Persons who are participating in other clinical trials; 6. Persons, in the opinion of investigator, are unsuitable to participate in the clinical trial for other reasons; 7. ases that the non-disease factors lead to the loss of transplant kidney or renal transplant recipients' death.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| vital sign;white blood cells;serum creatinine;blood uric acid;estimated GFR;MHC-?/CD20 rate;IL-2/IL-4 rate;CD4/CD8 rate;cell factor; | — |
Countries
China
Contacts
Kidney Department, the First Affiliated Hospital, Third Military Medical University